Related Articles
The protective effects of PCPA against monocrotaline-induced pulmonary arterial hypertension are mediated through the downregulation of NFAT-1 and NF-κB
Inhibitory effects of formononetin on the monocrotaline‑induced pulmonary arterial hypertension in rats
Protection against monocrotaline-induced pulmonary arterial hypertension and caveolin-1 downregulation by fluvastatin in rats
Protective effect of hydrogen sulfide on monocrotaline‑induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition
The effects of atorvastatin on pulmonary arterial hypertension and expression of p38, p27, and Jab1 in rats